Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Genomic Health's IPO Adds $60M For Breast Cancer Test

Sep. 30, 2005

By Jennifer Boggs

Sirna's RNAi Work Lands $250M Deal With Allergan

Sep. 30, 2005

By Jennifer Boggs

Genomic Health's IPO Adds $60M For Breast Cancer Test

Sep. 30, 2005

By Jennifer Boggs

Insmed's Growth Hormone Approvable; 'Issues' Remain

Sep. 29, 2005

By Jennifer Boggs

Scynexis, Merial Enter Potential $150M Animal Health Partnership

Sep. 29, 2005

By Jennifer Boggs

Scynexis, Merial Enter Potential $150M Animal Health Partnership

Sep. 29, 2005

By Jennifer Boggs

Insmed's Growth Hormone Approvable; 'Issues' Remain

Sep. 29, 2005

By Jennifer Boggs

Banking On MyoCell, Bioheart Gets Series D Round Of $19M

Sep. 28, 2005

By Jennifer Boggs

Sunesis Prices $42M IPO To Fuel Oncology Pipeline

Sep. 28, 2005

By Jennifer Boggs

Sunesis Prices $42M IPO To Fuel Oncology Pipeline

Sep. 28, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...